Harmony Biosciences Holdings, Inc. Common Stock (NASDAQ: HRMY) last traded at $38.15, up 0.21% on the session. The quote above updates while this page is open; the figures below are drawn from Harmony Biosciences Holdings, Inc. Common Stock’s own filings and are restated only when a new one is published.
Harmony Biosciences Holdings, Inc. Common Stock trades on NASDAQ under the ticker HRMY. Its market capitalisation is $2.22 billion.
Valuation measures for Harmony Biosciences Holdings, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.22B |
|---|---|
| Enterprise value | $2.05B |
| P/E ratio | 12.39 |
| Price / sales | 2.31 |
| Price / book | 2.22 |
| Beta | 0.55 |
Trailing-twelve-month figures tagged in Harmony Biosciences Holdings, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $959.90M |
|---|---|
| Net income (TTM) | $181.27M |
| EPS (TTM) | $3.08 |
| Gross margin | 75.42% |
| Operating margin | 24.03% |
| Return on equity | 18.14% |
| Cash | $549.77M |
Range and volume for HRMY over the past 52 weeks.
| 52-week high | $40.87 |
|---|---|
| 52-week low | $25.52 |
| Volume | 353.9K |
| Average volume | 826.4K |
| Previous close | $38.07 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.